MedPath

An observational study to assess clinical impact of hair serum in Indian Patients with patterned hair loss

Recruiting
Conditions
Androgenic alopecia, unspecified,
Registration Number
CTRI/2023/07/055158
Lead Sponsor
Not applicable
Brief Summary

This is a Multicenter, Case-cohort, Observational study planned to assess Safety & Clinical impact of Curcumin longa based Hair Serum  in Indian Patients with hair loss.

Cuticapil serum is a combination of biotinyl GHK with apigenin a flavonoid from citrus and oleanolic acid from olive tree leaves. Also liposome based Caffeine and Cressantine works on unique mechanism to improve hair growth. It is also enriched with Biotin Plus. 

The rationale of this study is to assess real world clinical safety and efficacy of Cuticapil Stem hair serum in patterned hair loss in men & women in India.



As the study will be conducted in the real life setting, study medication will be prescribed by the investigator and the patients will purchase the drug from the pharmacy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Male or female patients of 18 or above with diagnosis of hair loss Hair shedding > 6 month Clinical diagnosis of male AGA Grade III, Grade IV, Grade V and clinical diagnosis of FPHL Grade II and Grade III naïve cases or treated with 5% Minoxidil.
  • Patients with no known allergy.
  • Patients who agree to refrain from using hair dye, oil treatment or spa treatment, perming or straightening during the treatment/observation period Patients who agree to use Non ketoconazole based shampoo.
Exclusion Criteria

Cosmetic hair treatments 1 month prior to enrolment Patients with Hemoglobin level below 10.5 Patients with thyroid disorders or other systemic disorders including T2DM, Hypertension, HIV, Hepatitis, Anemia, Heart disorders, Cancer & undergone chemotherapy, Depression, any psychiatric disorders and those taking drugs which could cause alopecia Pregnant and lactating females Patients with scalp disease Heavy Smokers & heavy drinkers Patients on crash diets.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in hair count shedding after shampooing from baseline at 10 weeks.at 10 week
Change in hair count with Pull test from baseline at 10 weeks.at 10 week
Global photography assessment at 10 week as centrally adjudicated scale scoreat 10 week
for hair count.at 10 week
Secondary Outcome Measures
NameTimeMethod
Safety assessment of the hair serumAGA, FPHL, Patient Global Assessment

Trial Locations

Locations (9)

Asia Institute of Hair Transplant

🇮🇳

Pune, MAHARASHTRA, India

DERMALIFE REDEFINE YOURSELF

🇮🇳

West, DELHI, India

Dr Ganjoos Skin & Cosmetology Centre

🇮🇳

West, DELHI, India

Dr Manjul Agrwals Clinic

🇮🇳

West, DELHI, India

Dr Shreyas Kamath - Clinic

🇮🇳

Mumbai, MAHARASHTRA, India

Dr Vaidyas Skin & Laser Clinic

🇮🇳

Pune, MAHARASHTRA, India

GNH Excel Medical Centre

🇮🇳

West, DELHI, India

RD Clinic

🇮🇳

Mumbai, MAHARASHTRA, India

Rejoice Aesthetic Experts

🇮🇳

Mumbai, MAHARASHTRA, India

Asia Institute of Hair Transplant
🇮🇳Pune, MAHARASHTRA, India
Dr Pradeep Kumari
Principal investigator
9623050666
Drpkumari263@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.